BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17222611)

  • 1. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.
    Kouba E; Smith A; McRackan D; Wallen EM; Pruthi RS
    J Urol; 2007 Feb; 177(2):466-70; discussion 470. PubMed ID: 17222611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome.
    Lamb GW; Bromwich EJ; Vasey P; Aitchison M
    Urology; 2004 Nov; 64(5):909-13. PubMed ID: 15533476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
    Abou Youssif T; Kassouf W; Steinberg J; Aprikian AG; Laplante MP; Tanguay S
    Cancer; 2007 Sep; 110(5):1010-4. PubMed ID: 17628489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
    O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
    BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of renal masses followed expectantly.
    Kassouf W; Aprikian AG; Laplante M; Tanguay S
    J Urol; 2004 Jan; 171(1):111-3; discussion 113. PubMed ID: 14665856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth characteristics of renal cortical tumors in patients managed by watchful waiting.
    Sowery RD; Siemens DR
    Can J Urol; 2004 Oct; 11(5):2407-10. PubMed ID: 15579229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management of small renal tumors.
    Matsuzaki M; Kawano Y; Morikawa H; Shiga Y; Murata H; Komatsu H
    Hinyokika Kiyo; 2007 Apr; 53(4):207-11. PubMed ID: 17515068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed intervention of sporadic renal masses undergoing active surveillance.
    Crispen PL; Viterbo R; Fox EB; Greenberg RE; Chen DY; Uzzo RG
    Cancer; 2008 Mar; 112(5):1051-7. PubMed ID: 18286513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active surveillance of renal masses in elderly patients.
    Abouassaly R; Lane BR; Novick AC
    J Urol; 2008 Aug; 180(2):505-8; discussion 508-9. PubMed ID: 18550113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance for renal cortical neoplasms.
    Rosales JC; Haramis G; Moreno J; Badani K; Benson MC; McKiernan J; Casazza C; Landman J
    J Urol; 2010 May; 183(5):1698-702. PubMed ID: 20299038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
    Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
    Rais-Bahrami S; Guzzo TJ; Jarrett TW; Kavoussi LR; Allaf ME
    BJU Int; 2009 May; 103(10):1355-8. PubMed ID: 19239459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
    Chawla SN; Crispen PL; Hanlon AL; Greenberg RE; Chen DY; Uzzo RG
    J Urol; 2006 Feb; 175(2):425-31. PubMed ID: 16406965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of low risk superficial bladder tumors.
    Pruthi RS; Baldwin N; Bhalani V; Wallen EM
    J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.